Like HintMD

announced 5/19/2020 via BNC Analysis

Revance Therapeutics, Inc., will acquire HintMD

synopsis: Revance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic and therapeutic offerings, is to acquire Hint, Inc., a privately held company doing business under the name HintMD, which has created an integrated financial technology (fintech) platform for the aesthetics industry.
buyer: Revance Therapeutics, Inc. (RVNC:$0.19)
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection. "
target: HintMD
Hint, Inc. is a privately held company doing business under the name HintMD, which has created an integrated financial technology (fintech) platform for the aesthetics industry. They offer customized POS payment systems and Patient Subscriptions and Loyalty Programs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/4/2019 via PR Newswire

Growflow Corp., acquired LeafOps

synopsis: GrowFlow, the leading provider of Traceability software in Washington State, announced the acquisition of LeafOps POS. LeafOps serves the dispensary and retail market and has customers in seven states including California, Oregon, and Arizona. LeafOps provides smart inventory management and point of sale software.
buyer: Growflow Corp.
GrowFlow is the leading provider of Traceability software in Washington State. GrowFlow is the easiest to use, complete traceability and sales system. "
target: LeafOps
LeafOps was built from the ground up with enterprise-grade technology for the cannabis industry. LeafOps provides smart inventory management and point of sale software that empowers dispensaries.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 7/6/2017 via PR Newswire

MassRoots, will acquire Odava, Inc.

synopsis: MassRoots, Inc. and Odava, Inc., a leading regulatory compliance platform for the cannabis industry, have executed a Definitive Agreement for MassRoots to acquire Odava for cash and shares of MassRoots' common stock. Odava is a leading platform technology that provides compliance, point-of-sale, & supply chain management for the cannabis industry.
buyer: MassRoots (OTCPK:MSRT:$0.39)
MassRoots is one of the largest technology platforms for the regulated cannabis industry. The company's Apple iOS and Android mobile apps enable consumers to provide community-driven reviews of cannabis strains and products, enabling consumers to make educated cannabis purchasing decisions. "
target: Odava, Inc.
Odava is one of the leading technology platforms providing compliance, point-of-sale, and supply chain management for the cannabis industry. Its team is made of technology-industry veterans with more than 35 years of experience in building Internet-scale infrastructure.
price ($mm)
$1.76
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 12/15/2016 via PR Newswire

MassRoots, will acquire Whaxy

synopsis: MassRoots, Inc. reports it has entered into a definitive agreement to acquire DDDigtal Inc. d.b.a. "Whaxy". Since its launch, Whaxy's menu management and online ordering platform for licensed cannabis businesses has processed over $5 million in volume across 40,000 unique transactions. The acquisition is subject to customary closing conditions.
buyer: MassRoots (OTCPK:MSRT:$0.39)
MassRoots is one of the largest technology platforms for the regulated cannabis industry. The company's mobile apps enables consumers to provide community-driven reviews of cannabis strains and products, enabling consumers to make educated cannabis purchasing decisions. "
target: Whaxy
Whaxy's platform seamlessly integrates with nearly every major point-of-sale system used dispensaries and will allow for live pricing, online ordering, and product feedback, Whaxy has been used by some of the leading businesses in the industry.
price ($mm)
$2.51
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 1/12/2012 via PR Newswire

Weedmaps, LLC, acquired MMJMenu, LLC

synopsis: General Cannabis, Inc., a technology-based Internet marketing services company, announced that its wholly-owned subsidiary, WeedMaps Media, Inc., has signed documents to acquire the assets of MMJMenu, LLC, the medical marijuana industry's leading provider of seed-to-sale collective management and point of sale software.
buyer parent: General Cannabis, Inc.
buyer: Weedmaps, LLC
WeedMaps.com is a community where medical marijuana patients connect with other patients in their geographic region to freely discuss and review local cannabis co-operatives, dispensaries, medical doctors and delivery services. Dispensaries list their services for free. "
target: MMJMenu, LLC
MMJMenu provides business management software for dispensaries and growers, enabling them to track their medical cannabis from seed to sale. MMJMenu.com is used by hundreds of medical marijuana businesses in California, Colorado, Michigan, Montana, Washington as well as in Canada.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/10/2018 via BusinessWire

Fishawack Group, acquired Blue Latitude Health

synopsis: The Fishawack Group of Companies, one of the world’s largest independent medical communications and medical marketing organizations, has acquired Blue Latitude Health, a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency. BLH focuses on the commercialization of healthcare innovations.
buyer: Fishawack Group
Based in the UK, the Fishawack Group of Companies is one of the largest independent medical communications specialists with offices in the UK, USA, Switzerland, and India. For over 17 years, they have been partnering with global and regional pharmaceutical, biotechnology, and medical device clients."
target: Blue Latitude Health
Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency. Focused on the commercialization of healthcare innovations, they operate globally and regionally at a brand, portfolio and organizational level.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/1/2016 via PR Newswire

VSS Medical Technologies, acquired Legato Healthcare Marketing, Inc.

synopsis: VSS Medical Technologies, Inc. announced it purchased a majority interest in Legato Healthcare Marketing, Inc. Legato Healthcare Marketing is a healthcare marketing agency headquartered in De Pere, Wisconsin. Legato provides specialized marketing solutions to rural health organizations, specialty clinics and medical equipment companies.
buyer: VSS Medical Technologies
VSS Medical Technologies is a healthcare informatics company that offers a diverse portfolio of hyper-specialized software and professional service solutions. They are an innovative technology company that leverages cutting-edge tools to address some of the most comple "
target: Legato Healthcare Marketing, Inc.
Legato Healthcare Marketing is a healthcare marketing agency headquartered in De Pere, Wisconsin. Legato provides specialized marketing solutions to rural health organizations, specialty clinics and medical equipment companies.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/3/2015 via GlobeNewswire

A.D.A.M., Inc., acquired Via Media Health

synopsis: Ebix, Inc., a leading supplier of On-Demand software and E-commerce services to the insurance, financial and healthcare industries, announced that it has acquired Via Media Health, one of India's leading health content & communication companies. Via Media Health will be immediately integrated into its A.D.A.M. Health Information Exchange Division.
buyer parent: Ebix, Inc.
buyer: A.D.A.M., Inc. (ADAM:$0.00)
Founded in 1990, A.D.A.M., Animated Dissection of Anatomy for Medicine, has been a worldwide leading provider of consumer health information and benefits technology solutions to health care organizations, hospitals, benefits brokers, employers, consumers, and educational institutions. "
target: Via Media Health
Via Media Health is a 13 years old communication, consulting, and networking organization focused on innovative health communication solutions in India.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/25/2015 via BNC Analysis

Quattro Direct LLC, acquired FWD>Direct

synopsis: Quattro, a marketing and advertising agency based in Berwyn that counts Comcast, New Penn Financial and Ditech as clients, says it has acquired Downingtown-based FWD>Direct a provider of marketing services for healthcare providers.
buyer: Quattro Direct LLC
Quattro is a marketing and advertising agency based in Berwyn that counts Comcast, New Penn Financial and Ditech as clients. They offer services in strategic marketing, creative services, digital, production management, and data media. "
target: FWD>Direct
Based in Downingtown, PA, FWD>Direct helps healthcare providers cost effectively attract and retain more customers. Their services include Strategic Planning, Program Development, Online (Search Marketing, Display, Retargeting, Email and Social Media), Direct Mail, Direct Response TV, and more.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 2/28/2013 via BusinessWire

WCG Company, acquired Partners for Medical Education, Inc.

synopsis: WCG, an integrated communications firm that is part of the W2O Group network of companies, announced its acquisition of Partners for Medical Education, Inc., which will deepen and expand the company’s direct-to-patient advocacy and education offerings for its healthcare clients.
buyer parent: W2O Group
buyer: WCG Company
WCG is an independent strategic communications firm providing integrated solutions built upon clear analytics, with the aim of achieving competitive advantage for a growing spectrum of leading companies and organizations. "
target: Partners for Medical Education, Inc.
Led by Sharron Ames, a 30-year integrated marketing expert, Partners for Medical Education, Inc. delivers best-in-class patient programs and educational materials for people living with rare diseases, chronic illnesses and life-threatening conditions.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 4/2/2018 via GlobeNewswire

MINDBODY Inc., acquired Booker Software

synopsis: MINDBODY Inc., the leading technology platform for the wellness services industry, announced that it has completed the acquisition of Booker Software, a leading cloud-based business management platform for salons and spas, and the provider of Frederick, a fast-growing, automated marketing software for wellness businesses.
buyer: MINDBODY Inc. (MB:$228.91)
MINDBODY Inc. is the leading technology platform for the wellness services industry. Local wellness entrepreneurs worldwide use MINDBODY's integrated software and payments platform to run, market and build their businesses. "
target: Booker Software
Booker is the leading technology platform for running and growing salons and spas, delivering an end-to-end solution for business owners to compete in the rapidly growing market for local services. Booker and Frederick offer online booking, CRM, marketing automation, staff management, and POS.
price ($mm)
$150
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 3/13/2018 via BNC Analysis

True Nature Holding, Inc., will acquire LocalPetRX

synopsis: True Nature Holding, Inc., a development stage company focused on the consolidation of the compounding pharmacy industry, will acquire LocalPetRX, a provider of software and services that allow local veterinarians to manage their patient's pet prescriptions online, communicate with their patients, and operate a customized online store.
buyer: True Nature Holding, Inc. (OTCPK:TNTY:$0.00)
True Nature Holding, Inc. is a public, development stage company focused on the consolidation of the compounding pharmacy industry through opportunistic acquisitions to create a national platform of quality-focused, profitable and efficient businesses to serve both human and veterinary markets. "
target: LocalPetRX
LocalPetRX is a provider of software and services aimed at allowing local pharmacy operators to effective enter the veterinary marketplaces. LocalPetRX allows veterinarians to manage their patient's pet prescriptions online, communicate with their patients, and operate a customized online store.
price ($mm)
$0.05
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 3/29/2017 via Company Press Release

Serviceplan Group, acquired Beck & Co

synopsis: Serviceplan Group has acquired Beck & Co, a renowned independent pharmaceutical agency in Germany and Austria with offices in Munich and Vienna. The Beck & Co. team bring with them a high degree of creativity, medical content and digital pharmaceutical marketing.
buyer: Serviceplan Group
The Serviceplan Group is the largest and most broadly based owner- and partner-managed agency group in Europe. Founded as a traditional advertising agency, Serviceplan soon developed the concept of ‘House of Communication’ that brings together all modern communication disciplines under one umbrella."
target: Beck & Co
Beck & Co. is a full-service agency specialising in the healthcare field. Patient communication and awareness campaigns play an increasingly important role, and Beck & Co. mainly attend to customers' needs with prescription products.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 12/1/2014 via Market Wire

Northstar Healthcare Inc., acquired Athas Health, LLC

synopsis: Northstar Healthcare announced it has acquired Athas Health. Based in Dallas, TX, Athas focuses on the marketing and delivery of specialized healthcare services in 7 states. Athas has gained a well-earned reputation in the marketing of spine and migraine procedures under the trademarks of North American Spine and Migraine Treatment Centers.
buyer: Northstar Healthcare Inc. (TSX:NHC:$57.93)
Northstar Healthcare is a full-service healthcare development and management company. With a collective leadership experience that includes developing and managing over 100 surgical centers, Northstar constantly strives to provide superior medical care and increased patient satisfaction. "
target: Athas Health, LLC
Athas Health offers relevant information and treatment options to patients seeking help for various health-related issues. Athas can coordinate a patient’s education on different treatment options available and direct them to the best team of physicians to help them get the optimal care available.
price ($mm)
$27
rev ($mm)
$29
EBITDA ($mm)
$2
EV / rev
1.2x
EV / EBITDA
18.1x
announced 5/19/2020 via BNC Analysis

Revance Therapeutics, Inc., will acquire HintMD

synopsis: Revance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic and therapeutic offerings, is to acquire Hint, Inc., a privately held company doing business under the name HintMD, which has created an integrated financial technology (fintech) platform for the aesthetics industry.
buyer: Revance Therapeutics, Inc. (RVNC:$0.19)
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection. "
target: HintMD
Hint, Inc. is a privately held company doing business under the name HintMD, which has created an integrated financial technology (fintech) platform for the aesthetics industry. They offer customized POS payment systems and Patient Subscriptions and Loyalty Programs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
announced 5/19/2020 via BNC Analysis

Revance Therapeutics, Inc., will acquire HintMD

synopsis: Revance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic and therapeutic offerings, is to acquire Hint, Inc., a privately held company doing business under the name HintMD, which has created an integrated financial technology (fintech) platform for the aesthetics industry.
buyer: Revance Therapeutics, Inc. (RVNC:$0.19)
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection. "
target: HintMD
Hint, Inc. is a privately held company doing business under the name HintMD, which has created an integrated financial technology (fintech) platform for the aesthetics industry. They offer customized POS payment systems and Patient Subscriptions and Loyalty Programs.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 7/13/2017 via BusinessWire

Genoa Healthcare, acquired Medication Management Systems, Inc.

synopsis: The nation’s leading behavioral health pharmacy and telepsychiatry company, Genoa, a QoL Healthcare Company, announced the acquisition of Medication Management Systems, Inc., a Minneapolis-based provider of comprehensive medication therapy management services and technology for complex high-risk patients.
buyer: Genoa Healthcare
Genoa, a QoL Healthcare Company, has been serving the behavioral health community for more than 15 years. The company provides pharmacy and telepsychiatry services to more than 550,000 individuals annually in 48 states & the District of Columbia, filling more than 12 million prescriptions per year. "
target: Medication Management Systems, Inc.
Medication Management Systems, Inc. provides comprehensive, patient–centered medication management services and technology to improve medication therapy by identifying and resolving patients’ medication therapy problems.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 11/15/2017 via BusinessWire

ConnectiveRx, acquired Careform

synopsis: ConnectiveRx, a leader in helping patients with affordability, access and medication adherence messaging, has acquired Careform, a leader in technology-enabled “hub” services driving patient and provider engagement and support.
buyer: ConnectiveRx
Headquartered in Whippany, New Jersey, ConnectiveRx delivers affordability and adherence messaging solutions through all stages of the patient’s medication journey to help them get and stay on their medications. The company provides these solutions to over 125 biopharmaceutical manufacturers. "
target: Careform
Based in Pittsburgh, Pennsylvania, Careform was founded in 2012 to simplify access to specialty pharmaceuticals through technology-enabled patient support services. BrandHub delivers inventory management, EHR integration and therapy cycle management to identify and remove barriers to patient access.
price ($mm)
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA
closed 8/2/2017 via BNC Analysis

Cannabis Sativa, Inc., acquired PrestoDoctor

synopsis: Cannabis Sativa. Inc., a company that develops and promotes natural cannabis products, has acquired a 51% stake in PrestoCorp (a.k.a. PrestoDoctor), an online telemedicine platform providing access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation using secure video conferencing technology.
buyer: Cannabis Sativa, Inc. (OTCPK:CBDS:$0.03)
Cannabis Sativa, Inc. develops and promotes natural cannabis products. The Company is engaged in the research, development and licensing of natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. "
target: PrestoDoctor
PrestoDoctor is an online telemedicine platform providing access to knowledgeable physicians for a safe and confidential way to get a medical marijuana recommendation using secure video conferencing technology. Appointments are 10-15 minutes long, and can be scheduled and completed in the same day.
price ($mm)
$2.39*
rev ($mm)
EBITDA ($mm)
EV / rev
EV / EBITDA

Like HintMD


read more

HintMD

LeafOps

Odava, Inc.

Whaxy

MMJMenu, LLC

Blue Latitude Health

Legato Healthcare Marketing, Inc.

Via Media Health

FWD>Direct

Partners for Medical Education, Inc.

Booker Software

LocalPetRX

Beck & Co

Athas Health, LLC

read more

HintMD

read more

HintMD

read more

Medication Management Systems, Inc.

Careform

PrestoDoctor

Geography
Matching Companies
Ticker: OTCPK:ICRD
 
 
 
 
 
 
 
 
International Card Establishment
International Card Establishment, Inc. provides credit card and electronic transaction processing services to merchants across the United States. They are specialists in Marijuana Merchant Accounts, and an online source for everything related to high risk merchant accounts and payment processing.
year
2016
rev ($mm)
$2.67
EBITDA ($mm)
($0.16)
EBIT ($mm)
($0.20)
Net Income ($mm)
Employees
16
  • drill down
  • watch
Ticker: RVNC
 
 
 
 
 
 
 
 
Revance Therapeutics, Inc.
Revance Therapeutics, Inc.
Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection.
year
2020
rev ($mm)
$0.19
EBITDA ($mm)
($185.77)
EBIT ($mm)
($188.79)
Net Income ($mm)
Employees
193
  • drill down
  • watch
Ticker:
 
 
 
 
 
 
 
 
Novartis AG
Novartis AG
Novartis is a Swiss multinational pharmaceutical company based in Basel, Switzerland. It is one of the largest pharmaceutical companies by both market capitalization and sales. Their focus is on cancer, immunology, dermatology, cardiovascular, renal and more.
year
2019
rev ($mm)
$48,677.00
EBITDA ($mm)
$15,532.00
EBIT ($mm)
$11,351.00
Net Income ($mm)
$11,732.00
Employees
103914
  • drill down
  • watch
Ticker: OTCPK:PRLX
 
 
 
 
 
 
 
 
Parallax Health Sciences, Inc.
Parallax Health Sciences, Inc. is an innovative biomedical healthcare company delivering consumer-centric products and services in the areas of pharmaceuticals, digital health and remote patient monitoring, behavioral health and point of care diagnostics.
year
2016
rev ($mm)
$18.98
EBITDA ($mm)
($1.31)
EBIT ($mm)
($1.43)
Net Income ($mm)
Employees
34
  • drill down
  • watch
Ticker: ABC
 
 
 
 
 
 
 
 
AmerisourceBergen Corporation
AmerisourceBergen Corporation
AmerisourceBergen provides pharmaceutical products, value-driving services and business solutions that improve access to care. Tens of thousands of healthcare providers, veterinary practices and livestock producers trust them as their partner in the pharmaceutical supply chain.
year
2019
rev ($mm)
$175,151.50
EBITDA ($mm)
$2,276.42
EBIT ($mm)
$1,735.61
Net Income ($mm)
$929.88
Employees
20500
  • drill down
  • watch
Ticker: ADRX
 
 
 
 
 
 
 
 
Andrx Corporation
Andrx Corporation is committed to providing: high quality, cost effective pharmaceuticals to our customers and to patients; sustained profit and revenue growth to our stockholders; and an employee culture that is stimulating and rewarding.
year
2005
rev ($mm)
$1,145.10
EBITDA ($mm)
$132.00
EBIT ($mm)
$95.90
Net Income ($mm)
$65.70
Employees
0
  • drill down
  • watch
Ticker: MDZ
 
 
 
 
 
 
 
 
MDS, Inc.
MDS Inc. is a global life sciences company that provides market-leading products and services that are used by its customers for the development of drugs, and the diagnosis and treatment of disease. The Company has more than 5,000 employees in 29 countries and net revenues of more than US$1.2 bil.
year
2009
rev ($mm)
$231.00
EBITDA ($mm)
$37.00
EBIT ($mm)
$13.00
Net Income ($mm)
Employees
3600
  • drill down
  • watch
Ticker: ABPI
 
 
 
 
 
 
 
 
Accentia Biopharmaceuticals, Inc.
Accentia Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the development of Revimmune as a system of care for the treatment of autoimmune diseases. The company, through its subsidiary, Biovest International, Inc.
year
2012
rev ($mm)
$4.05
EBITDA ($mm)
($11.29)
EBIT ($mm)
($11.54)
Net Income ($mm)
Employees
54
  • drill down
  • watch
Ticker: DB:MRK
 
 
 
 
 
 
 
 
Merck KGaA
Merck KGaA
Merck KGaA is a German multinational pharmaceutical, chemical and life sciences company. Merck is the world's oldest operating chemical and pharmaceutical company. The group develops a variety of prescription medicines and specialty chemicals.
year
2019
rev ($mm)
$17,234.26
EBITDA ($mm)
$4,219.33
EBIT ($mm)
$2,268.49
Net Income ($mm)
$3,866.88
Employees
53051
  • drill down
  • watch
Ticker: LSE:BTG
 
 
 
 
 
 
 
 
BTG International Ltd.
BTG is focused on developing innovative products in specialist areas of medicine to better serve doctors and patients. Their growing portfolio of Interventional Medicine products is designed to advance the treatment of cancer, severe emphysema, severe blood clots, and varicose veins.
year
2016
rev ($mm)
$646.34
EBITDA ($mm)
$150.64
EBIT ($mm)
$89.00
Net Income ($mm)
$28.38
Employees
1370
  • drill down
  • watch
Ticker: BSE:531637
 
 
 
 
 
 
 
 
Sword and Shield Pharma Ltd.
Sword and Shield Pharma Ltd.
Sword & Shield Pharma is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. They offer a portfolio of products including Active Pharmaceutical Ingredients, generics, differentiated formulations and News Chemical Entities.
year
2016
rev ($mm)
EBITDA ($mm)
EBIT ($mm)
Net Income ($mm)
Employees
  • drill down
  • watch
Ticker: OTCPK:MATN
 
 
 
 
 
 
 
 
Mateon Therapeutics, Inc.
Mateon Therapeutics, Inc.
Mateon Therapeutics is a biopharmaceutical company developing vascular disrupting agents (VDAs) which may be used in combination with currently available anti-angiogenic agents to improve the treatment of cancer, specifically orphan oncology indications.
year
2018
rev ($mm)
EBITDA ($mm)
($0.68)
EBIT ($mm)
($0.71)
Net Income ($mm)
Employees
0
  • drill down
  • watch